Pulmonary Hypertension
Pulmonary Hypertension (PH) is a serious condition characterized by high blood pressure in the blood vessels that supply the lungs, leading to symptoms like shortness of breath, fatigue, and chest pain.
Pulmonary Hypertension: Sotatercept Study
We are investigating the safety and effects of sotatercept in individuals with pulmonary hypertension due to heart failure. This study aims to understand how well the treatment works over time.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have pulmonary hypertension (high blood pressure in the lungs)?
- Are you pregnant or breastfeeding?
- Do you have severe liver disease or cirrhosis (serious liver scarring)?
- Have you had a heart transplant or are you waiting for one?
- Have you had more than one heart valve replacement or repair?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hopital Erasme
Cardiology
Negenmanneke, Belgium
Centre Hospitalier Regional D'Angers
Department of Respiratory and Sleep Medicine
Angers, France
Bicetre Hospital
Service de pneumologie et réanimation respiratoire
Croulebarbe, France
Sponsor: Merck Sharp & Dohme LLC
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.